OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased densities of T and B lymphocytes indicate neuroinflammation in subgroups of schizophrenia and mood disorder patients
Konstantin Schlaaff, Henrik Dobrowolny, Thomas Frodl, et al.
Brain Behavior and Immunity (2020) Vol. 88, pp. 497-506
Closed Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives
Evgeny A. Ermakov, Mark M. Melamud, Valentina N. Buneva, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 92

Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin
Myles Corrigan, Aoife M. O’Rourke, Barry Moran, et al.
Neuronal Signaling (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 47

Chemokine Dysregulation and Neuroinflammation in Schizophrenia: A Systematic Review
Evgeny A. Ermakov, Irina A. Mednova, Anastasiia S. Boiko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2215-2215
Open Access | Times Cited: 46

Inflammatory mediators in major depression and bipolar disorder
Sara Poletti, Mario Gennaro Mazza, Francesco Benedetti
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 27

Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers
Sara Poletti, Raffaella Zanardi, Alessandra Mandelli, et al.
Brain Behavior and Immunity (2024) Vol. 118, pp. 52-68
Open Access | Times Cited: 23

Genetic contribution to microglial activation in schizophrenia
Marja Koskuvi, Elina Pörsti, Tristen Hewitt, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 9, pp. 2622-2633
Open Access | Times Cited: 20

Neuroinflammation in Mood Disorders: Role of Regulatory Immune Cells
Moisés Evandro Bauer, Antônio Lúcio Teixeira
NeuroImmunoModulation (2021) Vol. 28, Iss. 3, pp. 99-107
Open Access | Times Cited: 82

Neuroinflammation in schizophrenia: the role of nuclear factor kappa B
Caitlin E. Murphy, Adam K. Walker, Cynthia Shannon Weickert
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 82

Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia
Tertia D. Purves-Tyson, Kate Robinson, Amelia M. Brown, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 80

Blood–Brain Barrier Dysfunction in the Pathogenesis of Major Depressive Disorder
Shusheng Wu, Yuye Yin, Longfei Du
Cellular and Molecular Neurobiology (2021) Vol. 42, Iss. 8, pp. 2571-2591
Closed Access | Times Cited: 70

Impaired regulatory T cell control of astroglial overdrive and microglial pruning in schizophrenia
Fabiana Corsi‐Zuelli, J.F.W. Deakin
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 637-653
Closed Access | Times Cited: 67

Neutrophil-lymphocyte ratios as inflammatory biomarkers in psychiatric patients
Tracy Bhikram, Paul Sandor
Brain Behavior and Immunity (2022) Vol. 105, pp. 237-246
Closed Access | Times Cited: 60

Blood brain barrier and inflammation in depression
Eva M. Medina‐Rodríguez, Eléonore Beurel
Neurobiology of Disease (2022) Vol. 175, pp. 105926-105926
Open Access | Times Cited: 41

A preliminary choroid plexus volumetric study in individuals with psychosis
Olcay Şenay, Magdalena Seethaler, Nikos Makris, et al.
Human Brain Mapping (2023) Vol. 44, Iss. 6, pp. 2465-2478
Open Access | Times Cited: 32

Inflammation-related transcripts define “high” and “low” subgroups of individuals with schizophrenia and bipolar disorder in the midbrain
Yunting Zhu, Samantha J. Owens, Caitlin E. Murphy, et al.
Brain Behavior and Immunity (2022) Vol. 105, pp. 149-159
Closed Access | Times Cited: 31

Shared Genetic Loci Between Schizophrenia and White Blood Cell Counts Suggest Genetically Determined Systemic Immune Abnormalities
Nils Eiel Steen, Zillur Rahman, Attila Szabó, et al.
Schizophrenia Bulletin (2023) Vol. 49, Iss. 5, pp. 1345-1354
Open Access | Times Cited: 17

Brain microvascular endothelial cells and blood-brain barrier dysfunction in psychotic disorders
Paulo Lizano, Sovannarath Pong, Stephanie Santarriaga, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3698-3708
Closed Access | Times Cited: 17

Inflammatory Markers in Substance Use and Mood Disorders: A Neuroimaging Perspective
Khushbu Agarwal, Peter Manza, Marquis Chapman, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 26

Choroid plexus volume is increased in mood disorders and associates with circulating inflammatory cytokines
B. Bravi, Elisa Melloni, Marco Paolini, et al.
Brain Behavior and Immunity (2023) Vol. 116, pp. 52-61
Closed Access | Times Cited: 13

Matrix metalloproteinase 9 (MMP-9) activity, hippocampal extracellular free water, and cognitive deficits are associated with each other in early phase psychosis
Johanna Seitz‐Holland, Yasser Alemán‐Gómez, Kang Ik K. Cho, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 7, pp. 1140-1150
Open Access | Times Cited: 5

Unraveling the Role of the Blood-Brain Barrier in the Pathophysiology of Depression: Recent Advances and Future Perspectives
Shamili Mariya Varghese, Shashikant Patel, Amritasree Nandan, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10398-10447
Closed Access | Times Cited: 5

Page 1 - Next Page

Scroll to top